Publications
2 shownMulticentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)
The purpose of this study was to evaluate the efficacy of gefitinib and the feasibility of screening for epidermal growth factor receptor (EGFR) mutations among select patients ...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 254
- Institution
- Kindai University
External Links
Identifiers
- ORCID
- 0009-0008-7007-2524
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.